NCT04824599

Brief Summary

Pectoralis nerves plane block (PECS) first described by Blanco in 2011 has become part of postoperative pain management in breast surgery, thoracic surgery and thoracic trauma. The combination of low complication risk and easiness in mastering of PECS block has made it an interesting alternative to thoracic epidural anesthesia (TEDA) and paravertebral blockade (PVB) for pain treatment after breast surgery. Several studies showed good results when PECS was compared to PVB. PECS blockade however is a procedure requiring some resources in the operating room. An alternative approach is to inject local anesthetics (LA) in the operation field by the surgeon. The hypothesis' tested in this study is primarily: that PECS blockade is superior to LA being injected by surgeon in the operating field measured by end points such as: post-operative pain, post-operative analgesics use, post-operative nausea or vomiting (PONV) and length of stay in the post anesthesia care unit (PACU).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 19, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 24, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2022

Completed
Last Updated

September 7, 2023

Status Verified

September 1, 2023

Enrollment Period

1.2 years

First QC Date

March 24, 2021

Last Update Submit

September 3, 2023

Conditions

Keywords

Segmental Mastectomy,AnalgesiaRegional anesthesiaBreast surgery

Outcome Measures

Primary Outcomes (2)

  • maximal pain in PACU measured with 11 point numerical rating scale (NRS)

    NRS scale is a validated for assessment of pain. It is a 11 point scale (0-10) used to estimate severity of postoperative pain. On NRS scale the higher value indicates more severe symptoms.

    measured at discharge from PACU (on average 4 hours).

  • Intraoperative fentanyl use

    dose of fentanyl used during surgery in milligrams \[mg\].

    Time is measured from start of the anesthesia until discharge to PACU (on average 3 hours)

Secondary Outcomes (5)

  • Postoperative analgesic use

    measured at 24 hours postoperatively.

  • Maximal postoperative nausea and vomiting(PONV) in PACU measured with 11 point numerical rating scale (NRS)

    measured at discharge from PACU (on average 4 hours).

  • Length of stay in PACU

    on average 4 hours.

  • Maximal postoperative nausea and vomiting(PONV) after discharge from PACU measured with 11 point numerical rating scale (NRS)

    24 hours

  • Maximal pain after discharge from PACU measured with 11 point numerical rating scale (NRS)

    24 hours

Study Arms (2)

PECS+subcutaneus local anesthetic infiltration

ACTIVE COMPARATOR

Preoperative ultrasound-led PECS II blockade with ropivacaine 3,75mg/ml (2mg/kg). After surgery - wound infiltration by the surgeon with ropivacaine 2mg/ml (1mg/kg).

Procedure: PECS IIProcedure: Subcutaneus local anesthetic infiltrationDrug: RopivacaineDevice: bk medical Flex Focus 500 Ultrasound Machine

Local anesthetic infiltration

ACTIVE COMPARATOR

Prior to scrubbing surgeon infiltrates the thought incision area with ropivacaine 3,75/ml (1mg/kg). Perioperatively after removal of the tumor follows the deep infiltration of the wound with ropivacaine 3,75mg/ml (2mg/kg).

Procedure: Local anesthetic infiltrationDrug: Ropivacaine

Interventions

PECS IIPROCEDURE

Pectoral nerves block (PECS II) is performed with the help of ultrasound. Two injection are performed in two fascial planes. One between pectoralis major muscle and serratus anterior muscle. Second one between pectoralis major and minor muscles.

Also known as: Pectoral nerves block
PECS+subcutaneus local anesthetic infiltration

Ropivacaine is administered by surgeon prior to scrubbing and following the removal of the tumor.

Local anesthetic infiltration

Ropivacaine is administered by the surgeon at the end of surgery

PECS+subcutaneus local anesthetic infiltration

Local anesthetic ropivacaine is administered in both study arms according to the study protocol

Also known as: Local anesthetic
Local anesthetic infiltrationPECS+subcutaneus local anesthetic infiltration

Ultrasound with linear probe is performed. Using in-plane technique a correct placement of the injection needle is secured.

Also known as: High Frequency Linear 8870 probe
PECS+subcutaneus local anesthetic infiltration

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women scheduled for partial mastectomy (lumpectomy).

You may not qualify if:

  • Scheduled cryosection
  • Axillary node dissection
  • Re-resection
  • Age under 18 or unable to give an informed concent
  • Chronic pain history
  • Allergy to local anesthetics
  • History of active drug addiction
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central Hospital in Karlstad

Karlstad, Värmland County, 652 30, Sweden

Location

Related Publications (7)

  • Jacobs A, Lemoine A, Joshi GP, Van de Velde M, Bonnet F; PROSPECT Working Group collaborators#. PROSPECT guideline for oncological breast surgery: a systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2020 May;75(5):664-673. doi: 10.1111/anae.14964. Epub 2020 Jan 26.

    PMID: 31984479BACKGROUND
  • Blanco R. The 'pecs block': a novel technique for providing analgesia after breast surgery. Anaesthesia. 2011 Sep;66(9):847-8. doi: 10.1111/j.1365-2044.2011.06838.x. No abstract available.

    PMID: 21831090BACKGROUND
  • Apfel CC, Roewer N, Korttila K. How to study postoperative nausea and vomiting. Acta Anaesthesiol Scand. 2002 Sep;46(8):921-8. doi: 10.1034/j.1399-6576.2002.460801.x.

    PMID: 12190791BACKGROUND
  • Woodworth GE, Ivie RMJ, Nelson SM, Walker CM, Maniker RB. Perioperative Breast Analgesia: A Qualitative Review of Anatomy and Regional Techniques. Reg Anesth Pain Med. 2017 Sep/Oct;42(5):609-631. doi: 10.1097/AAP.0000000000000641.

    PMID: 28820803BACKGROUND
  • Habib AS, Kertai MD, Cooter M, Greenup RA, Hwang S. Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study. Reg Anesth Pain Med. 2019 Feb;44(2):192-199. doi: 10.1136/rapm-2018-000040. Epub 2019 Jan 5.

    PMID: 30700614BACKGROUND
  • Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain. 2011 Oct;152(10):2399-2404. doi: 10.1016/j.pain.2011.07.005.

    PMID: 21856077BACKGROUND
  • Eisler P, Zimmermann S, Henningsson R. Interpectoral and Pectoserratus Plane Block vs. Local Anesthetic Infiltration for Partial Mastectomy: A Prospective Randomized Trial. Pain Res Manag. 2024 Mar 20;2024:9989997. doi: 10.1155/2024/9989997. eCollection 2024.

MeSH Terms

Conditions

Breast NeoplasmsAgnosia

Interventions

RopivacaineAnesthetics, Local

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Study Officials

  • Ragnar Henningsson, PhD

    Örebro University, Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant in Anesthesiology and Intensive care

Study Record Dates

First Submitted

March 24, 2021

First Posted

April 1, 2021

Study Start

February 19, 2021

Primary Completion

May 1, 2022

Study Completion

May 1, 2022

Last Updated

September 7, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations